Amkay Products Limited has announced its 19th Annual General Meeting (AGM) to be held on September 30, 2026. The company has also released its Annual Report for the financial year 2025-26, detailing its performance and future outlook. Shareholders will be able to attend the AGM virtually and participate via video conferencing. The report provides a comprehensive overview of the company’s operations, financial results, and strategic initiatives.
19th Annual General Meeting Announced
Amkay Products Limited has officially announced its 19th Annual General Meeting (AGM). The meeting is scheduled to take place on Wednesday, September 30, 2026, at 04:00 p.m. Shareholders will have the opportunity to participate remotely through Video Conferencing (VC) or Other Audio Visual Means (OAVM). The AGM will cover ordinary business, including the receipt, consideration, and adoption of the Audited Standalone Financial Statements for the financial year ended March 31, 2026, along with the reports of the Board and Auditors. Additionally, the re-appointment of Mr. Kashyap Pravin Mody as Director will be sought.
Annual Report 2025-26 Released
The company has also made its Annual Report for the financial year 2025-26 available. This report provides a detailed look at Amkay Products Limited’s performance during the fiscal year. It includes an overview of the company’s business, financial results, management’s discussion and analysis, and various statutory disclosures. The report highlights the company’s focus on manufacturing and trading medical devices and healthcare consumables, as well as its commitment to innovation, quality, and customer-centricity.
Financial Performance Highlights
For the financial year ended March 31, 2026, Amkay Products Limited reported revenue from operations of approximately ₹4,202.70 lakh, an increase from the previous year. The net profit after tax for the year stood at approximately ₹231.10 lakh. The report details the company’s financial results, including total income, expenses, and profit before and after tax. It also provides key financial ratios and an analysis of significant changes in these ratios during the fiscal year.
Operational Overview and Strategy
Amkay Products Limited operates in the manufacturing and trading of medical devices, disposables, and other healthcare products. The company emphasizes its core principles of precision, trust, quality, and consistency. Its strategy focuses on expanding market presence, driving innovation, and maintaining customer-centricity. The company is committed to developing a comprehensive ‘Made in India’ range of quality medical products.
Corporate Governance and Compliance
The report also details the company’s corporate governance structure, including the Board of Directors, committees, and key managerial personnel. It assures compliance with applicable laws and regulations, including secretarial standards and listing obligations. The company emphasizes its commitment to ethical business practices and transparency.
Source: BSE
